AN
Adlai Nortye(ANL)
NORTH BRUNSWICK, NJ
BiotechnologyFocus: Cancer & Metabolic Disease Treatments
Adlai Nortye is a life sciences company focused on Cancer & Metabolic Disease Treatments.
OncologyMetabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
AN9025 oral capsule
Solid Tumors (Phase 1)Clinical Trials (1)
NCT07252479Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
Phase 1Pelareorep
Advanced or Metastatic Breast CancerClinical Trials (1)
NCT05519059Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast Cancer
Phase 1AN0025
Esophageal CancerClinical Trials (1)
NCT05191667AN0025 and Chemoradiotherapy Combination in Esophageal Cancer
Phase 1AN4005-dose level 0
Advanced Solid TumorClinical Trials (1)
NCT04999384First in Human, Dose Escalation Study of AN4005
Phase 1Phase 1
Clinical Trials (1)
NCT04975958Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors
Phase 1Phase 1
Clinical Trials (1)
NCT03152370Preoperative Radiotherapy and E7046 in Rectum Cancer
Phase 1AN0025
Lung Cancer Stage IIIClinical Trials (1)
NCT05358691A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
Phase 1Phase 1
Buparlisib & Paclitaxel
Head and Neck CancerClinical Trials (1)
NCT04338399The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2023
Portfolio: 8 clinical trials